AstraZeneca COVID vaccine – European product information – produced using human fetal cell line and GMO
Page 2:
Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant]). . .
. . . One dose (0.5ml) contains: Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)*, not less than 2.5 × 108 infectious units (Inf.U)
*Produced in genetically modified human embryonic kidney (HEK)293 cells and by recombinant DNA technology.
This product contains genetically modified organisms (GMOs). . . .
Page 11:
7. MARKETING AUTHORISATION HOLDER
AstraZeneca AB
SE-151 85 Södertälje
Sweden . . .
10. . . . Detailed information on this medicinal product is available on the website of the European Medicines Agency . . .
Note: HEK293 is a human fetal cell line derived from an aborted baby, apparently in the early 1970s, according to the standard accounts.
https://en.wikipedia.org/wiki/HEK_293_cells
During the COVID-19 pandemic, anti-vaccination activists noted that HEK 293 cells are used in the manufacturing of the Oxford–AstraZeneca COVID-19 vaccine (AKA AZD1222). The cells are filtered out of the final products.